Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ACC 2017: SURTAVI Supports Intermediate-Risk Intervention For Medtronic's CoreValve

Mar 21 2017

• By Reed Miller

Core Valve In Situ — Medtronic's CoreValve transcatheter aortic valve in situ • Source: SOURCE: Medtronic PLC

Related Content

US FDA Approves First Intermediate-Risk Indication For TAVR

Aug 18 2016

<em>Sapien</em> Heart Valve Gets FDA Panel Nod For High-Risk Surgical Patients

Jun 18 2012

Expanded Indication For Edwards’ Sapien 3 Squarely In Sight

Apr 06 2016

ACC 2016 BEST OF THE REST: Surgery Trials, More CoreValve Data, Leadless Pacemakers, Drug-Filled Stents, And More

Apr 07 2016

TCT 2015: More TAVR Results, Super-Thin Strut Stents, And Percutaneous Heart Pumps

Oct 29 2015

Related Companies

Medtronic plc

Additional Topics

Clinical Trials Research & Development Cardiology Medical Device

More from Cardiology

More from Device Area

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window